San Francisco, CA - Anastomosis Devices Market was
valued at 15.74 Million in 2016 and is expected to continue growing at a higher
rate. Factors such as rise in surgical procedures with rising incidences of
cardiovascular and GT diseases are likely to contribute to the market growth in
the forecast period. Overall, the anastomosis devices market is expected to
cross a CAGR of 5.2% in the forecast period.
Surgical procedures have now turned into a perplexed form
for cardiac surgeons right from the inception of coronary arteries bypass
grafts and minimally invasive techniques. Suture technique for coronary anastomosis
is becoming insufficient to suffice new demands from surgeons hence a need
arises for alternative techniques to perform coronary bypasses. Due to the
recent medical advancements, sutureless devices are based on memory shape metal
alloy, synthetic, and biologic glue combined or non-combined with metallic
framework and laser bonding using organic soldering techniques.
Request a PDF Sample
@ https://www.millioninsights.com/industry-reports/anastomosis-devices-market/request-sample
Anastomosis devices are easy to use and reduce the
dependency on surgeons, which is the analytical factor for long-term potency.
The key element of sutures is placed between graft vessels and target and any
distortion might result into obstruction of flow. Therefore, anastomotic
devices are made available for minimally invasive or endoscopic use to reduce
the heart operations via limited incisions. For instance, the heartflo
anastomotic device is a micromechanical-suturing device for coronary artery
bypass grafting. However, an ideal anastomotic method is considered only when
compression anastomosis having no foreign bodies left at anastomotic site.
Anastomosis devices industry is segmented based on product,
application, and geography. Reusable and disposable categories form the
bifurcation for product category in the market. “Application” segment for
anastomosis devices market include general surgeries, cardiovascular diseases,
orthopaedic surgeries, and ophthalmic surgeries.
Geographical segmentation for anastomosis devices industry
spans North America, Latin America, Europe, Asia-Pacific, Middle East and
Africa. North America anastomosis devices market is expected to rise at a
higher CAGR in the forecast period due to rising medical assistance for
cardiovascular diseases. Asia-Pacific’s anastomosis devices industry is likely
to expand at a staggering CAGR in the forthcoming period due to rise in young
workforce, change in lifestyle leading to occurrence of chronic as well as
acute ailments.
The key players in the anastomosis devices industry include
Medtronic; LivaNova PLC; MAQUET Holding B.V. & Co. KG., Dextera Surgical
Inc., Vitalitec International Inc., Synovis Micro Companies Alliance Inc., and
Ethicon US, LLC.
Regional Analysis For
Anastomosis Devices Market:
For comprehensive understanding of market dynamics, the
global Anastomosis Devices Market is analyzed across key geographies namely: North
America, Europe, Asia-Pacific, Latin America and Africa. Each of these regions
is analyzed on basis of market findings across major countries in these regions
for a macro-level understanding of the market.
Significant Features
that are under Offering and Key Highlights of the Reports:
1
Detailed overview of Anastomosis Devices Market
2
Changing market dynamics of the industry
3
In-depth market segmentation by Type,
Application etc
4
Historical, current and projected market size in
terms of volume and value
5
Recent industry trends and developments
6
Competitive landscape of Anastomosis Devices
Market
7
Strategies of key players and product offerings
8
Potential and niche segments/regions exhibiting
promising growth.
For More Technical
Insights, Download Brochure @ https://www.millioninsights.com/industry-reports/anastomosis-devices-market
No comments:
Post a Comment